Genetic evidence for repurposing of glucagon-like peptide-1 receptor agonists to prevent chronic liver diseases
- PMID: 38490731
- DOI: 10.1136/gutjnl-2024-332254
Genetic evidence for repurposing of glucagon-like peptide-1 receptor agonists to prevent chronic liver diseases
Keywords: DIABETES MELLITUS; HEPATOCELLULAR CARCINOMA; NONALCOHOLIC STEATOHEPATITIS.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes.Gut. 2024 Apr 5;73(5):835-843. doi: 10.1136/gutjnl-2023-330962. Gut. 2024. PMID: 38253482 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources